List of Tables
Table 1. Quetiapine Fumarate Market Trends
Table 2. Quetiapine Fumarate Market Drivers & Opportunity
Table 3. Quetiapine Fumarate Market Challenges
Table 4. Quetiapine Fumarate Market Restraints
Table 5. Global Quetiapine Fumarate Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Quetiapine Fumarate Revenue Market Share by Company (2020-2025)
Table 7. Global Quetiapine Fumarate Sales Volume by Company (2020-2025) & (MT)
Table 8. Global Quetiapine Fumarate Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Quetiapine Fumarate Price by Company (2020-2025) & (USD/Kg)
Table 10. Key Manufacturers Quetiapine Fumarate Manufacturing Base and Headquarters
Table 11. Key Manufacturers Quetiapine Fumarate Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Quetiapine Fumarate
Table 13. Global Quetiapine Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quetiapine Fumarate as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Quetiapine Fumarate Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Quetiapine Fumarate Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Quetiapine Fumarate Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Quetiapine Fumarate Sales Market Share in Value by Type (2020-2025)
Table 20. Global Quetiapine Fumarate Sales Market Share in Value by Type (2026-2031)
Table 21. Global Quetiapine Fumarate Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
Table 22. Global Quetiapine Fumarate Sales Volume by Type (2020-2025) & (MT)
Table 23. Global Quetiapine Fumarate Sales Volume by Type (2026-2031) & (MT)
Table 24. Global Quetiapine Fumarate Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Quetiapine Fumarate Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Quetiapine Fumarate Price by Type (2020-2025) & (USD/Kg)
Table 27. Global Quetiapine Fumarate Price by Type (2026-2031) & (USD/Kg)
Table 28. Global Quetiapine Fumarate Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Quetiapine Fumarate Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Quetiapine Fumarate Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Quetiapine Fumarate Sales Market Share in Value by Application (2020-2025)
Table 32. Global Quetiapine Fumarate Sales Market Share in Value by Application (2026-2031)
Table 33. Global Quetiapine Fumarate Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
Table 34. Global Quetiapine Fumarate Sales Volume by Application (2020-2025) & (MT)
Table 35. Global Quetiapine Fumarate Sales Volume by Application (2026-2031) & (MT)
Table 36. Global Quetiapine Fumarate Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Quetiapine Fumarate Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Quetiapine Fumarate Price by Application (2020-2025) & (USD/Kg)
Table 39. Global Quetiapine Fumarate Price by Application (2026-2031) & (USD/Kg)
Table 40. Global Quetiapine Fumarate Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Quetiapine Fumarate Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Quetiapine Fumarate Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Quetiapine Fumarate Sales Value by Region (2020-2025) & (%)
Table 44. Global Quetiapine Fumarate Sales Value by Region (2026-2031) & (%)
Table 45. Global Quetiapine Fumarate Sales Volume by Region (MT): 2020 VS 2024 VS 2031
Table 46. Global Quetiapine Fumarate Sales Volume by Region (2020-2025) & (MT)
Table 47. Global Quetiapine Fumarate Sales Volume by Region (2026-2031) & (MT)
Table 48. Global Quetiapine Fumarate Sales Volume by Region (2020-2025) & (%)
Table 49. Global Quetiapine Fumarate Sales Volume by Region (2026-2031) & (%)
Table 50. Global Quetiapine Fumarate Average Price by Region (2020-2025) & (USD/Kg)
Table 51. Global Quetiapine Fumarate Average Price by Region (2026-2031) & (USD/Kg)
Table 52. Key Countries/Regions Quetiapine Fumarate Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Quetiapine Fumarate Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Quetiapine Fumarate Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Quetiapine Fumarate Sales Volume, (2020-2025) & (MT)
Table 56. Key Countries/Regions Quetiapine Fumarate Sales Volume, (2026-2031) & (MT)
Table 57. AstraZeneca Company Information
Table 58. AstraZeneca Introduction and Business Overview
Table 59. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 60. AstraZeneca Quetiapine Fumarate Product Offerings
Table 61. AstraZeneca Recent Development
Table 62. Intas Company Information
Table 63. Intas Introduction and Business Overview
Table 64. Intas Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 65. Intas Quetiapine Fumarate Product Offerings
Table 66. Intas Recent Development
Table 67. TAPI Company Information
Table 68. TAPI Introduction and Business Overview
Table 69. TAPI Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 70. TAPI Quetiapine Fumarate Product Offerings
Table 71. TAPI Recent Development
Table 72. Accord Company Information
Table 73. Accord Introduction and Business Overview
Table 74. Accord Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Accord Quetiapine Fumarate Product Offerings
Table 76. Accord Recent Development
Table 77. Hexal Company Information
Table 78. Hexal Introduction and Business Overview
Table 79. Hexal Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Hexal Quetiapine Fumarate Product Offerings
Table 81. Hexal Recent Development
Table 82. Dr.Reddy's Company Information
Table 83. Dr.Reddy's Introduction and Business Overview
Table 84. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Dr.Reddy's Quetiapine Fumarate Product Offerings
Table 86. Dr.Reddy's Recent Development
Table 87. Lupin Company Information
Table 88. Lupin Introduction and Business Overview
Table 89. Lupin Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Lupin Quetiapine Fumarate Product Offerings
Table 91. Lupin Recent Development
Table 92. Sun Pharmaceutical Company Information
Table 93. Sun Pharmaceutical Introduction and Business Overview
Table 94. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Sun Pharmaceutical Quetiapine Fumarate Product Offerings
Table 96. Sun Pharmaceutical Recent Development
Table 97. Hunan Dongting Pharm Company Information
Table 98. Hunan Dongting Pharm Introduction and Business Overview
Table 99. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. Hunan Dongting Pharm Quetiapine Fumarate Product Offerings
Table 101. Hunan Dongting Pharm Recent Development
Table 102. SuZhou NO.4 Phamaceutical Factory Company Information
Table 103. SuZhou NO.4 Phamaceutical Factory Introduction and Business Overview
Table 104. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Offerings
Table 106. SuZhou NO.4 Phamaceutical Factory Recent Development
Table 107. Fuan Pharmaceutical Company Information
Table 108. Fuan Pharmaceutical Introduction and Business Overview
Table 109. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. Fuan Pharmaceutical Quetiapine Fumarate Product Offerings
Table 111. Fuan Pharmaceutical Recent Development
Table 112. Zhejiang Supor Pharmaceuticals Company Information
Table 113. Zhejiang Supor Pharmaceuticals Introduction and Business Overview
Table 114. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Offerings
Table 116. Zhejiang Supor Pharmaceuticals Recent Development
Table 117. Zhejiang Huahai Pharmaceutical Company Information
Table 118. Zhejiang Huahai Pharmaceutical Introduction and Business Overview
Table 119. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Offerings
Table 121. Zhejiang Huahai Pharmaceutical Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Quetiapine Fumarate Downstream Customers
Table 125. Quetiapine Fumarate Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Quetiapine Fumarate Product Picture
Figure 2. Global Quetiapine Fumarate Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Quetiapine Fumarate Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Quetiapine Fumarate Sales Volume (2020-2031) & (MT)
Figure 5. Global Quetiapine Fumarate Sales Price (2020-2031) & (USD/Kg)
Figure 6. Quetiapine Fumarate Report Years Considered
Figure 7. Global Quetiapine Fumarate Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Quetiapine Fumarate Players Sales Volume Ranking (2024) & (MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Quetiapine Fumarate Revenue in 2024
Figure 10. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Immediate Release Tablets Picture
Figure 12. Extended Release Tablets Picture
Figure 13. Global Quetiapine Fumarate Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Quetiapine Fumarate Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Quetiapine Fumarate Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
Figure 16. Global Quetiapine Fumarate Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Quetiapine Fumarate Price by Type (2020-2031) & (USD/Kg)
Figure 18. Product Picture of Adult
Figure 19. Product Picture of Others
Figure 20. Global Quetiapine Fumarate Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Quetiapine Fumarate Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Quetiapine Fumarate Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
Figure 23. Global Quetiapine Fumarate Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Quetiapine Fumarate Price by Application (2020-2031) & (USD/Kg)
Figure 25. North America Quetiapine Fumarate Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Quetiapine Fumarate Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Quetiapine Fumarate Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Quetiapine Fumarate Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Quetiapine Fumarate Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Quetiapine Fumarate Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Quetiapine Fumarate Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Quetiapine Fumarate Sales Volume (%), (2020-2031)
Figure 37. United States Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Quetiapine Fumarate Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Quetiapine Fumarate Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Quetiapine Fumarate Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Quetiapine Fumarate Sales Value by Application (%), 2024 VS 2031
Figure 43. China Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Quetiapine Fumarate Sales Value by Type (%), 2024 VS 2031
Figure 45. China Quetiapine Fumarate Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Quetiapine Fumarate Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Quetiapine Fumarate Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Quetiapine Fumarate Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Quetiapine Fumarate Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Quetiapine Fumarate Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Quetiapine Fumarate Sales Value by Application (%), 2024 VS 2031
Figure 55. India Quetiapine Fumarate Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Quetiapine Fumarate Sales Value by Type (%), 2024 VS 2031
Figure 57. India Quetiapine Fumarate Sales Value by Application (%), 2024 VS 2031
Figure 58. Quetiapine Fumarate Industrial Chain
Figure 59. Quetiapine Fumarate Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
